BCTG Holdings, LLC 13D and 13G filings for Tango Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-02 07:07 am Sale |
2024-12-30 | 13D | Tango Therapeutics, Inc. TNGX |
BCTG Holdings, LLC | 10,740,385 10.000% |
-4,473,668 (-29.40%) |
Filing |
| 2023-10-18 5:23 pm Purchase |
2023-10-16 | 13D | Tango Therapeutics, Inc. TNGX |
BCTG Holdings, LLC | 15,214,053 15.000% |
1,075,000 (+7.60%) |
Filing |
| 2023-08-16 4:40 pm Purchase |
2023-08-11 | 13D | Tango Therapeutics, Inc. TNGX |
BCTG Holdings, LLC | 14,139,053 13.900% |
7,150,603 (+102.32%) |
Filing |
| 2022-01-04 5:03 pm Unchanged |
2021-08-10 | 13D | Tango Therapeutics, Inc. TNGX |
BCTG Holdings, LLC | 6,988,450 8.000% |
0 (Unchanged) |
Filing |
| 2021-08-20 4:31 pm Purchase |
2021-08-10 | 13D | Tango Therapeutics, Inc. TNGX |
BCTG Holdings, LLC | 6,988,450 8.300% |
6,988,450 (New Position) |
Filing |